Opus Point Partners Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q2 | – | Sell |
-11,439
| Closed | -$753K | – | 59 |
|
|
2016
Q1 | $753K | Sell |
11,439
-4,131
| -27% | -$272K | 0.58% | 38 |
|
|
2015
Q4 | $968K | Buy |
15,570
+7,689
| +98% | +$478K | 0.64% | 42 |
|
|
2015
Q3 | $528K | Sell |
7,881
-1,271
| -14% | -$85.2K | 0.29% | 40 |
|
|
2015
Q2 | $890K | Hold |
9,152
| – | – | 0.7% | 35 |
|
|
2015
Q1 | $855K | Hold |
9,152
| – | – | 0.72% | 38 |
|
|
2014
Q4 | $814K | Buy |
+9,152
| New | +$814K | 0.81% | 37 |
|